Versor Investments’s Aimmune Therapeutics AIMT Stock Holding History

Versor Investments’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-577,587	Closed	-$19.9M	–	307
2020 Q3	$19.9M	Buy	+577,587	New	+$12.3M	1.69%	16

Versor Investments's AIMT Position: Q4 2020 in Review

Versor Investments sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 577,587 shares — an estimated $19.9M sold.

Versor Investments first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $19.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Versor Investments reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Versor Investments sold 577,587 Aimmune Therapeutics shares in Q4 2020, an estimated $19.9M.
Versor Investments first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Versor Investments's Aimmune Therapeutics position peaked at $19.9M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Versor Investments's 13F filing for Q4 2020, filed 10 Feb 2021.